CLINICAL AND TRANSLATIONAL EPIDEMIOLOGY BRANCH SEEKS PROGRAM DIRECTOR
The successful candidate will have opportunities to conduct collaborative epidemiologic research, present findings at scientific meetings, and publish results in peer-reviewed journals. In addition to scientific management of grants and influencing the trajectory of research in cancer epidemiology, the successful candidate will have significant collaboration and leadership opportunities with scientists across NCI involved in large scientific endeavors and initiatives in areas of relevance to cancer epidemiology.
The position offers:
- Opportunities to develop initiatives on the cutting edge of cancer epidemiology,
- Responsibility for a diverse portfolio of grant-supported research,
- Opportunities for transdisciplinary collaboration,
- Research opportunities, and
- A scientifically energizing and collegial environment.
The Clinical and Translational Epidemiology Branch (CTEB) plans, develops, directs, coordinates, and evaluates a comprehensive program of epidemiologic research in human populations related to etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions. View more information about CTEB.
Qualifications for this position include a relevant doctoral or medical degree and formal training in epidemiology. Training, experience, or expertise in health services research, pharmacoepidemiology, cancer genomics, epidemiology, risk prediction, and/or the translation and implementation of research findings into clinical health applications is preferred.
Candidates must have a strong interest in developing and managing research initiatives for the extramural community (predominantly university-based) that will move forward our understanding of the clinical, lifestyle, and genomic factors that influence cancer progression, recurrence, survival, and other treatment adverse outcomes such as secondary cancers. Experience in developing and organizing scientific workshops, administering grant programs, and managing contracts is an asset, but not required.